MedTrace Logo

CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.

NCT03693833 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2021-07-07

No results posted yet for this study

Summary

A randomized, placebo-controlled trial with blinded outcome assessments will be conducted to evaluate the efficacy and safety of CBD in patients with Hand-OA and PsA during a 12-week treatment period.

Conditions

Interventions

DRUG

Cannabidiol

Cannabidiol (CBD) tablets of 10mg each

DRUG

Placebo Oral Tablet

Oral Placebo tablets of 10mg each

Sponsors & Collaborators

  • Aalborg University

    collaborator OTHER

  • Aalborg University Hospital

    lead OTHER

Principal Investigators

  • Jonathan Vela · Dept. of rheumatology Aalborg University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-28
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03693833 on ClinicalTrials.gov